DURHAM, N.C., TOWSON, Md., & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A special dedication ceremony was held today at Duke University Medical Center for the opening of the Duke IDF Center of Excellence for Primary Immunodeficiency Diseases. The Immune Deficiency Foundation (IDF), through a generous grant from Talecris Biotherapeutics totaling more than $125,000 over two years, has collaborated with Duke to make this center available to patients and physicians with the goal of increasing early diagnosis and improving treatment and care for patients with primary immunodeficiency diseases (PID). The center, housed in the Duke University Medical Center, includes some of the world’s leading experts and state-of-the-art facilities focusing on the research and clinical care of PID.
